CD70:对于综合癌症诊断和治疗的新兴目标
Jiatao Hu1, Jinxin Li1, Bo Yang1
1Department of Urology, Changhai Hospital, Naval Medical University, Shanghai, China.
Clinical and translational medicine
|July 9, 2025
概括
CD70是一种有前途的癌症标. 针对CD70的成像和治疗,包括CAR-T和CAR-NK细胞,显示出改善癌症诊断和治疗的潜力.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 分子成像学分子成像学
背景情况:
- CD70是一种瘤亡因子连接体,在各种血液和固体瘤中过度表达.
- 这种异常表达使CD70成为癌症诊断和治疗的有吸引力的目标.
研究的目的:
- 审查CD70向策略的诊断和治疗方面的进展.
- 讨论基于CD70的癌症治疗的当前挑战和未来方向.
主要方法:
- 对CD70向免疫PET/CT用于癌症诊断的审查.
- 针对CD70的治疗方法的总结:抗体与药物联合体,CAR-T,CAR-NK和单克隆抗体.
- 分析组合策略以提高抗瘤疗效.
主要成果:
- 针对CD70的免疫PET/CT增强了瘤检测,分期和治疗监测.
- 针对CD70的疗法显示出令人鼓舞的临床前和早期临床活性.
- 组合策略显示出改善抗瘤反应和克服耐药性的前景.
结论:
- 针对CD70的策略为癌症诊断和治疗提供了显著的潜力.
- 需要进一步的研究和临床翻译来克服现有的障碍.
- 推进针对CD70的方法需要机械的理解和战略的结合.
关键词:
卡特 - 卡特 - 卡特 - 卡特CD7070 CD7070 CD7070 CD70 CD70 CD70 CD70 CD70 CD70 CD70 CD70 CD70 CD70 CD70 CD70 CD70 CD70 CD70 CD70 CD70 CD70 CD70 CD70 CD70 CD70 CD70 CD70 CD70 CD70 CD70 CD70 CD70 CD70 CD70 CD70 CD70 CD70 CD70 CD70 CD70 CD70 CD70 CD70 CD70 CD70 CD70 CD70 CD70 CD70 CD70 CD70 CD70 CD70组合疗法治疗组合治疗.免疫-PET/CT/CT可以使用.有针对性的治疗.
相关概念视频
02:57Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
02:50Combination Therapies and Personalized Medicine
5.1K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.1K
02:49Cancer Therapies
8.0K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
8.0K
01:27Tumor Immunotherapy
665
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
665
02:56Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K